MIXED DYSLIPIDEMIA
Clinical trials for MIXED DYSLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED DYSLIPIDEMIA trials appear
Sign up with your email to follow new studies for MIXED DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental injection aims to tame dangerous blood fats
Disease control CompletedThis study tested whether an investigational drug called ARO-ANG3, given as injections under the skin, could safely lower unhealthy levels of fats in the blood (mixed dyslipidemia). It involved 204 adults who were already on stable cholesterol medication. Participants received ei…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Two drugs beat one in cholesterol battle
Disease control CompletedThis completed study tested if a two-drug combination (DW5421A/DW5421B) works better than a single drug (DW5421A) at lowering 'bad' LDL cholesterol in adults with high cholesterol or mixed lipid problems. About 184 participants were randomly assigned to take either the combinatio…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE3 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New drug shows promise in taming dangerous blood fats
Disease control CompletedThis study tested whether an experimental drug called plozasiran (ARO-APOC3) could safely and effectively lower unhealthy levels of fats and cholesterol in the blood, a condition called mixed dyslipidemia. Over 350 adults already on standard cholesterol medication were randomly a…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
First human test for new cholesterol pill
Knowledge-focused CompletedThis was an early safety study to see how the body absorbs and processes two forms of a new drug candidate, DW5124, intended to treat mixed dyslipidemia (a cholesterol and fat disorder). It involved 55 healthy adult volunteers to check for side effects and see if taking the drug …
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Massive 12,000-Patient review shows how well new cholesterol shots work
Knowledge-focused CompletedThis study looked back at the health records of nearly 12,000 adults in China with high cholesterol. Researchers wanted to see how well two newer types of injectable cholesterol medicines worked for people in everyday life, outside of a controlled trial. They compared the effecti…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC